title: Usage of granulocyte colony-stimulating factor every 2 days is clinically useful and cost-effective for febrile neutropenia during early courses of chemotherapy.
authors.affiliation: Cancer Center of Ehime University Hospital, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime 7910295, Japan. yoshiyak@m.ehime-u.ac.jp
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Yakushijin
authors.forename: Hisaharu
authors.initials: H
authors.lastname: Shikata
authors.forename: Ikue
authors.initials: I
authors.lastname: Takaoka
authors.forename: Tamami
authors.initials: T
authors.lastname: Horikawa
authors.forename: Kazuhito
authors.initials: K
authors.lastname: Takeuchi
authors.forename: Jun
authors.initials: J
authors.lastname: Yamanouchi
authors.forename: Taichi
authors.initials: T
authors.lastname: Azuma
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Narumi
authors.forename: Takaaki
authors.initials: T
authors.lastname: Hato
authors.forename: Masaki
authors.initials: M
authors.lastname: Yasukawa